Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.1K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K
Antimicrobial Proteins01:23

Antimicrobial Proteins

9.8K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
9.8K
Immunological Memory01:23

Immunological Memory

9.8K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
9.8K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

22
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
22
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

973
The pathophysiology of pneumonia involves the following steps:
973

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.

JAMA cardiology·2026
Same author

Left Atrial Reservoir Strain for Predicting Progression to End-Stage in Hypertrophic Cardiomyopathy.

European heart journal. Cardiovascular Imaging·2026
Same author

Practice and Perceptions on Extracorporeal Carbon Dioxide Removal in the Current Era: A Multinational Survey.

The clinical respiratory journal·2026
Same author

Best practices in specialized hypertrophic cardiomyopathy centers in the United States: a survey of cardiologists, nurses, pharmacists, patients, and patient advocates.

Future cardiology·2026
Same author

Adding volition to word processing: Expected utility norms for 80,000 English words and multiword expressions.

Behavior research methods·2026
Same author

Machine Learning Risk Stratification Approach Using Patient-Reported Outcomes for Forecasting Unplanned Health Care Use and Symptom Burden in Cancer Survivors.

JCO clinical cancer informatics·2026
Same journal

AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathies.

Med (New York, N.Y.)·2026
Same journal

Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementation.

Med (New York, N.Y.)·2026
Same journal

Atlas of human brain imaging-derived phenotypes and disease risk.

Med (New York, N.Y.)·2026
Same journal

Withdrawal effects following treatment discontinuation: A blind spot in evidence-based medicine.

Med (New York, N.Y.)·2026
Same journal

Rethinking parenteral nutrition as supportive therapy for neonatal sepsis.

Med (New York, N.Y.)·2026
Same journal

Power and sample-size estimation in human microbiome research.

Med (New York, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Oct 16, 2025

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

10.6K

Interferon gamma runs interference on persistent COVID-19.

Eric Isaac Elliott1, Andrew Wang2

  • 1Yale University School of Medicine, Department of Internal Medicine (Infectious Diseases), New Haven, CT, USA.

Med (New York, N.Y.)
|October 18, 2021
PubMed
Summary
This summary is machine-generated.

Five immunocompromised patients with prolonged COVID-19 showed successful recovery after treatment with interferon gamma (IFNγ). This precision medicine approach highlights IFNγ

More Related Videos

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

13.9K
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.5K

Related Experiment Videos

Last Updated: Oct 16, 2025

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

10.6K
Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

13.9K
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.5K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Virology

Background:

  • COVID-19 presents diverse disease endotypes requiring tailored treatments.
  • SARS-CoV-2 infection necessitates precision medicine for specific variants and illness stages.
  • Immunocompromised individuals are at higher risk for prolonged COVID-19.

Purpose of the Study:

  • To evaluate the efficacy of interferon gamma (IFNγ) in treating prolonged COVID-19 in immunocompromised patients.
  • To explore precision medicine strategies for managing severe SARS-CoV-2 infections.

Main Methods:

  • Case study of five immunocompromised patients with persistent COVID-19.
  • Treatment administered: interferon gamma (IFNγ).
  • Monitoring of patient recovery and viral load.

Main Results:

  • All five patients with prolonged COVID-19 achieved successful recovery following IFNγ treatment.
  • Interferon gamma demonstrated therapeutic potential in this patient cohort.

Conclusions:

  • Interferon gamma (IFNγ) is a viable precision medicine option for select immunocompromised patients with prolonged COVID-19.
  • Targeted antiviral therapies like IFNγ can effectively manage severe SARS-CoV-2 infections.